-Ph.D from the Univ. of Notre Dame & postdoctoral training from Duke University followed by 12+ years of leading preclinical & early clinical research at GlaxoSmithKline (GSK).
-Current therapeutic focus on cardio-metabolic disease (type 2 diabetes, obesity, cardiovascular disease).
-Analytic specialization in bioinformatics, statistics, data visualization & data mining of high-dimensional, complex datasets, including genomic/proteomic and clinical trials data.
•Strategic experience includes decision support to senior management for strategic planning, business intelligence & research programs in biomarkers, clinical genomics & molecular profiling.
-Specific research interests inc...